Skip to main content
SpringerLink
Log in

PET/CT in Cardiology

  • Chapter
PET/CT

  • 1281 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schelbert HR, Phelps ME, Hoffman EJ, et al. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol 1979;43:209–218.

    Article  PubMed  CAS  Google Scholar 

  2. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron emission tomography. N Engl J Med 1986;314:884–888.

    Article  PubMed  CAS  Google Scholar 

  3. Bergmann SR, Fox KA, Raud AL, et al. Quantification of regional myocardial blood flow in vivo with H2 15O. Circulation 1984;70:724–733.

    PubMed  CAS  Google Scholar 

  4. Bergmann SR. Quantification of myocardial perfusion with positron emission tomography. In: Bergmann SR, Sobel BE, editors. Positron Emission Tomography of the Heart. Mount Kisco, NY: Futura; 1992:97–127.

    Google Scholar 

  5. Yonekura Y, Tamaki N, Senda M, et al. Detection of coronary artery disease with 13N-ammonia and high-resolution positron-computed tomography. Am Heart J 1987;113:645–654.

    Article  PubMed  CAS  Google Scholar 

  6. Schelbert H, Phelps M, Huang S, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259–1272.

    PubMed  CAS  Google Scholar 

  7. Tamaki N, Yonekura Y, Senda M, et al. Myocardial positron computed tomography with 13N-ammonia at rest and during exercise. Eur J Nucl Med 1985;11:246–251.

    Article  PubMed  CAS  Google Scholar 

  8. Gould K, Goldstein R, Mullani N. Economic analysis of clinical positron emission tomography of the heart with rubidium-82. J Nucl Med 1989;30(5):707–717.

    PubMed  CAS  Google Scholar 

  9. Williams B, Jansen D, Wong L, et al. Positron emission tomography for the diagnosis of coronary artery disease: a non-university experience and correlation with coronary angiography. J Nucl Med 1989;30:845.

    Google Scholar 

  10. Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 1989;79:825–835.

    PubMed  CAS  Google Scholar 

  11. Stewart R, Schwaiger M, Molina E, et al. Comparison of rubidium-82, positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991;67:1303–1310.

    Article  PubMed  CAS  Google Scholar 

  12. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;31:1899–1905.

    PubMed  CAS  Google Scholar 

  13. Schwaiger M, Ziegler SI, Bengel FM. Assessment of myocardial blood flow with positron emission tomography. In: Pohost GM, O’Rourke RA, Berman DS, et al., editors. Imaging in Cardiovascular Disease. Philadelphia: Lippincott, Williams and Wilkins; 2000:195–212.

    Google Scholar 

  14. Gheorghiade M, Bonow RO. Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation 1998;97:282–289.

    PubMed  CAS  Google Scholar 

  15. The Multicenter Post Infarction Research Groups. Risk stratification and survival after myocardial infarction. N Engl J Med 1993;309:331–336.

    Google Scholar 

  16. Bonow RO, Dilsizian V. Thallium-201 for assessing myocardial viability. Semin Nucl Med 1991;21:230–241.

    Article  PubMed  CAS  Google Scholar 

  17. Pigott JD, Kouchoukos NT, Oberman A, et al. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985;5:1036–1045.

    Article  PubMed  CAS  Google Scholar 

  18. Baker DW, Jones R, Hodges J, et al. Management of heart failure III. The role of revascularization in treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994;272:1528–1534.

    Article  PubMed  CAS  Google Scholar 

  19. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151–1158.

    Article  PubMed  Google Scholar 

  20. Bax JJ, Poldermans D, Elhendy A, et al. Sensitivity, specificity, and predictive accuracies of various non invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:147–186.

    Article  PubMed  CAS  Google Scholar 

  21. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1041–1048.

    Article  Google Scholar 

  22. Kuhl HP, Beek AM, van deer Weerdt AP, et al. Myocardial viability in chronic ischemic heart disease. Comparison of contrast-enhanced magnetic resonance imaging with 18F-Fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003;41:1341–1348.

    Article  PubMed  Google Scholar 

  23. Berry JJ, Baker JA, Pieper KS, et al. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. J Nucl Med 1991;32:1518–1525.

    PubMed  CAS  Google Scholar 

  24. Nuutila P, Koivisto VA, Knuuti J, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 1992;89:1767–1774.

    Article  PubMed  CAS  Google Scholar 

  25. Knuuti J, Nuutila P, Ruotsalainen U, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992;33:1255–1262.

    PubMed  CAS  Google Scholar 

  26. Knuuti MJ, Yki-Jarvinen H, Voipio-Pulkki LM, et al. Enhancement of myocardial [fluorine-18] fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med 1994;35:989–998.

    PubMed  CAS  Google Scholar 

  27. Bax JJ, Patton JA, Poldermans D, et al. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med 2000;30:281–298.

    Article  PubMed  CAS  Google Scholar 

  28. Shaw LJ, Raggi P, Schisterman E, et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all cause mortality. Radiology 2003;228:826–833.

    PubMed  Google Scholar 

  29. Leber AW, Knez A, Von Ziegler F, et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 2005;46:147–154.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Duke University Medical Center, Durham, NC, USA

    Michael W. Hanson MD, FACC (Clinical Professor and Co-Director of Nuclear Cardiology)

  2. Division of Nuclear Medicine, Duke University Medical Center, Durham, NC, USA

    Michael W. Hanson MD, FACC (Clinical Professor and Co-Director of Nuclear Cardiology)

  3. Department of Radiology, Division of Nuclear Medicine, Duke University Medical Center, Durham, NC, USA

    Salvador Borges-Neto MD, FACC (Assistant Professor)

Authors
  1. Michael W. Hanson MD, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salvador Borges-Neto MD, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, Medical University of South Carolina, Charleston, SC, USA

    Ronald B. Workman Jr. MD (Resident) (Resident)

  2. Duke University Medical Center, Durham, NC, USA

    R. Edward Coleman MD (Professor Department of Radiology and Director of Nuclear Medicine) (Professor Department of Radiology and Director of Nuclear Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hanson, M.W., Borges-Neto, S. (2006). PET/CT in Cardiology. In: Workman, R.B., Coleman, R.E. (eds) PET/CT. Springer, New York, NY . https://doi.org/10.1007/978-0-387-38335-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-38335-4_12

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-32166-0

  • Online ISBN: 978-0-387-38335-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation